Exagen Inc logo

Exagen Inc

$ 4.59 -0.26 (-5.36%) 08:08 PM EST
P/E:
At Loss
P/B:
1.18
Market Cap:
$ 74.64M
Enterprise V:
$ 36.99M
Volume:
17.00K
Avg Vol (2M):
63.18K
Also Trade In:
Volume:
17.00K
Market Cap $:
74.64M
PE Ratio:
At Loss
Avg Vol (2-Month):
63.18K
Enterprise Value $:
36.99M
PB Ratio:
1.18
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Exagen Inc
NAICS : 541380 SIC : 8071
1261 Liberty Way, Suite C, Vista, CA, USA, 92081
Compare
Compare
AKU CNTG STIM AWH BDSX TRIB ENZ SERA CHEK PMD TMO DHR XSWX:LONN SHSE:603259 IQV ILMN A IDXX MTD LH
Traded in other countries / regions
E08A.Germany XGN.USA
Description
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Name Current Vs Industry Vs History
Cash-To-Debt 2.21
Equity-to-Asset 0.6
Debt-to-Equity 0.54
Debt-to-EBITDA -1.02
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.68
Distress
Grey
Safe
Beneish M-Score -2.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 9.59
9-Day RSI 20.61
14-Day RSI 28.98
6-1 Month Momentum % -10.18
12-1 Month Momentum % -41.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.3
Quick Ratio 9.3
Cash Ratio 7.98
Days Sales Outstanding 79.34
Days Payable 45.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.5

Financials (Next Earnings Date:2022-11-10 Est.)

XGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:XGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 44.296
EPS (TTM) ($) -2.22
Beta 0
Volatility % 62.03
14-Day RSI 28.98
14-Day ATR ($) 0.638873
20-Day SMA ($) 6.66525
12-1 Month Momentum % -41.69
52-Week Range ($) 4.15 - 14.9
Shares Outstanding (Mil) 16.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Exagen Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More